João Gabriel Sanchez Tavares da Silva

Mr. João Gabriel Sanchez Tavares da Silva

Associação Beneficente Síria - Hcor, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Appetite
Verified
Journal Article
Closed access
PSPriscila Sato
Priscila Sato
BLBárbara Hatzlhoffer Lourenço
Bárbara Hatzlhoffer Lourenço
João Gabriel Sanchez Tavares da SilvaJoão Gabriel Sanchez Tavares da Silva
João Gabriel Sanchez Tavares da Silva
FSFernanda Baeza Scagliusi
Fernanda Baeza Scagliusi

16 May 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CTCarla Andrea Trapé
Carla Andrea Trapé
CCCélia Maria Sivalli Campos
Célia Maria Sivalli Campos
COCintia de Freitas Oliveira
Cintia de Freitas Oliveira
João Gabriel Sanchez Tavares da SilvaJoão Gabriel Sanchez Tavares da Silva
João Gabriel Sanchez Tavares da Silva
LULiza Yurie Teruya Uchimura
Liza Yurie Teruya Uchimura
TYTatiana Yonekura
Tatiana Yonekura
Objectives: To systematically explore the concepts, types, and methodologies related to literature reviews and evidence synthesis. Methods: We conducted a scoping review using PubMed, Embase, Biblioteca Virtual da Saúde, grey literature, and websites of key international and national institutions, including the Cochrane Collaboration, Joanna Briggs Institute, Center for Reviews and Dissemination, Campbell Collaboration, and REBRATS, with searches completed through November 13, 2024. Studies were included if they identified or proposed theories and/or methodologies for evidence synthesis at international or national levels, with eligibility limited to studies published in English, Spanish, or Portuguese and no restrictions on publication year. Title and abstract screening was conducted independently by ten reviewers working in pairs, with a third reviewer resolving conflicts as needed, and full-text copies of potentially relevant articles were retrieved for further analysis. Results: The review included 99 studies employing a variety of evidence synthesis methods. A total of 71 terminologies for types of evidence synthesis were identified and grouped by conceptual and methodological similarities, resulting in 16 categories of evidence synthesis, each with clear differences in concepts and methods. Conclusions: The lack of standardization in defining and classifying review types challenges the scientific community by hindering study comparisons and appropriate methodology selection. Future research should explore the relationships between different review types and their outcomes, as well as the applicability of new methodologies across various fields.

10 November 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
ÂBÂngela Bersch-Ferreira
Ângela Bersch-Ferreira
RMRachel Helena Vieira Machado
Rachel Helena Vieira Machado
JOJúlia Oliveira
Júlia Oliveira
RSRenato Hideo Nakagawa Santos
Renato Hideo Nakagawa Santos
LSLucas R. da Silva
Lucas R. da Silva
AMAline Marcadenti
Aline Marcadenti
Background/Objectives: The optimal dietary approach for managing glycemic and metabolic control in type 2 diabetes (T2D) is still uncertain, though it should be tailored for clinical settings. Therefore, we sought to assess the impact of a multicomponent nutritional strategy on glycemic control in T2D patients within a public health system. Methods: NUGLIC was an open-label, parallel-group, superiority, multicenter randomized controlled trial. Participants aged 30 and older with poorly controlled T2D were randomly assigned to either (1) a personalized dietary prescription (control group, n = 185) or (2) a strategy involving targeted nutritional advising, mindfulness techniques, and short message services (NUGLIC [intervention] group, n = 186). The primary outcomes were glycated hemoglobin (HbA1c, %) measured after 24 weeks and glycemic control, defined as having an HbA1c > 7% at baseline and achieving ≤7% after follow-up, or having HbA1c ≤ 7% at baseline and reducing the use of glucose-lowering medications post-follow-up. The secondary outcomes included cardiometabolic features, self-care practices, diet quality, and quality of life. Results: A total of 371 participants were included in an intention-to-treat analysis for the primary outcomes. At six months, both groups exhibited a reduction in HbA1c levels compared to the baseline (NUGLIC group: −0.6% [95% confidence interval (CI) −0.9; −0.3], p < 0.001; control group: −0.5% [95% CI −0.7; −0.3], p < 0.001). However, no significant differences were observed between the groups in terms of HbA1c after follow-up (intervention group: 8.1%; control group: 8.3%; difference: −0.2% [95% CI −0.5; 0.1], p = 0.30) or glycemic control (NUGLIC group: 19.9%; control group: 18.9%; odds ratio 0.96 [95% CI 0.56; 1.67], p = 0.89). While the control group showed an improvement in overall diet quality, no significant differences emerged between the groups by the end of this study (p = 0.13). There were also no significant differences in other secondary outcomes nor in the use of glucose-lowering medications and adverse events after follow-up. Conclusions: The multicomponent nutritional strategy did not demonstrate superiority over personalized dietary prescriptions in achieving glycemic control for participants with poorly managed T2D. In this sense, both nutritional interventions could be used in clinical practice to improve HbA1c levels, considering the profile and preferences of individuals.

15 June 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
EAErlon Oliveira de Abreu-Silva
Erlon Oliveira de Abreu-Silva
RMRachel Machado
Rachel Machado
BSBianca Rodrigues dos Santos
Bianca Rodrigues dos Santos
FKFlávia Cristina Soares Kojima
Flávia Cristina Soares Kojima
RSRenato Hideo Nakagawa Santos
Renato Hideo Nakagawa Santos
AMAline Marcadenti
Aline Marcadenti
Background/Objectives: Familial hypercholesterolemia (FH) is an increasingly common inherited disorder that increases cardiovascular risk. Despite the importance of lifestyle interventions, adherence to a healthy diet among individuals with FH remains suboptimal. This pilot, multicenter, double-blind, placebo-controlled randomized trial aimed to evaluate the feasibility and preliminary effects of a culturally adapted cardioprotective diet (DICA-FH), alone or in combination with phytosterol and/or krill oil supplementation, on lipid parameters in Brazilian adults with probable or definitive FH. Methods: Between May and August 2023, 58 participants were enrolled across nine Brazilian centers and randomized (1:1:1:1) into four groups: DICA-FH + phytosterol placebo + krill oil placebo; DICA-FH + phytosterol 2 g/day + krill oil placebo; DICA-FH + phytosterol placebo + krill oil 2 g/day; and DICA-FH + phytosterol 2 g/day + krill oil 2 g/day. Interventions lasted 120 days. The primary outcomes were mean low-density lipoprotein cholesterol (LDL-c) and lipoprotein(a) (Lp[a]) levels, as well as adherence to treatment at follow-up. Secondary outcomes included mean levels of other lipids, frequency of adverse events, and assessment of protocol implementation components. All data were presented separately for the allocation groups: phytosterol vs. placebo and krill oil vs. placebo. Results: Mean age was 54.5 ± 13.7 years, and 58.6% were women. Both adherence to protocol (91.8% attendance; 79.1% investigational product intake) and retention (86.2%) were high. No significant differences between groups were found for LDL-c or Lp(a). However, regardless of allocation to active supplementation or placebo, a significant reduction in Lp(a) concentrations was observed following the DICA-FH intervention (median difference: −3.8 mg/dL [interquartile range: −7.5 to −1.2]; p < 0.01). Significant reductions in oxidized LDL (LDL-ox) and LDL-ox/LDL-c ratio were also observed in the overall sample (p < 0.01). Although not statistically significant, all groups showed improvements in diet quality after 120 days. No serious adverse events related to the interventions were reported. Additionally, most protocol implementation components were successfully achieved. Conclusions: The DICA-FH strategy, with or without supplementation, was safe and well-tolerated. Although not powered to detect clinical efficacy (which is acceptable in exploratory pilot trials), the study supports the feasibility of a larger trial and highlights the potential of dietary interventions in the management of HF.

8 December 2022 in REVISTA CIÊNCIAS EM SAÚDE
Verified
Journal Article
Open access
PDF file
AAAlanis Amorim Angotti
Alanis Amorim Angotti
João Gabriel Sanchez Tavares da SilvaJoão Gabriel Sanchez Tavares da Silva
João Gabriel Sanchez Tavares da Silva
PMPaula Andrea Martins
Paula Andrea Martins
Objective: To assess studies on the knowledge of health professionals regarding vegetarian diets. Methods: This integrative review was conducted from November to December 2020 and updated in January 2022 in 5 databases and the gray literature. Two investigators performed the article selection. The inclusion criteria were scientific articles with any study design that addressed the intended topic with no date or language limitation. Results: Eleven studies were included. The main common finding was that health professionals, except dietitians, were not satisfied with the available nutritional information in general, not only regarding vegetarian diets. Despite this gap, half of the studies showed a positive view by professionals concerning the vegetarian diet.Conclusions: Many professionals do not feel confident about encouraging a vegetarian diet since they do not know the details of its benefits and risks.

1 January 2025 in Jornal Vascular Brasileiro
Verified
Journal Article
Open access
PDF file
ARAndressa Pereira Rocha
Andressa Pereira Rocha
João Gabriel Sanchez Tavares da SilvaJoão Gabriel Sanchez Tavares da Silva
João Gabriel Sanchez Tavares da Silva
Resumo A associação entre a covid-19 e distúrbios de coagulação é discutida desde o início da pandemia, de modo que, passados 4 anos, é importante sistematizar as descobertas e evidências encontradas até o momento. O objetivo do estudo foi revisar e sintetizar as evidências científicas disponíveis sobre a relação entre a covid-19 e o desenvolvimento de tromboembolismo venoso. Foi realizada uma revisão sistemática rápida, com a busca conduzida em duas bases de dados eletrônicas, e incluídos artigos de revisão sistemática que avaliaram a associação entre a covid-19 e o desenvolvimento de tromboembolismo venoso, como trombose venosa profunda ou embolia pulmonar. Os estudos apontaram que pacientes hospitalizados por covid-19 apresentam maior risco de desenvolver tromboembolismo venoso, especialmente os internados em unidade de terapia intensiva. Valores de Dímero D elevado e o sexo masculino também foram associados a maiores riscos.